66 results
Page 3 of 4
8-K
EX-99.1
wfp989prq
5 Nov 19
Viking Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
7:15am
8-K
EX-99.1
m0nxhx2lz
1 Aug 19
Viking Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
4:24pm
8-K
EX-99.1
3hriq1k zejqei
2 May 19
Viking Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
4:05pm
8-K
EX-99.1
jp12baex4z xxjux
13 Mar 19
Viking Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update
4:12pm
CORRESP
84bpf41m1ljl8l5 9kgf
17 Jul 18
Correspondence with SEC
12:00am
8-K
EX-1.1
uzxo6 vb6izqvr3
7 Jun 18
Viking Therapeutics Announces Pricing of $67.5 Million Public Offering of Common Stock
1:41pm